This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Peripheral Vascular Devices Market

Market Insights on Peripheral Vascular Devices covering sales outlook, demand forecast & up-to-date key trends

Peripheral Vascular Devices Market By Product Type, Drug Eluting Balloons, End User & Region - Forecast 2022 - 2032

Peripheral Vascular Devices Market Snapshot

[409 Pages Report] The global peripheral vascular devices market is expected to enjoy a valuation of US$ 4.7 Bn by the end of the year 2022, and further expand at a CAGR of 6.6% to reach a valuation of ~US$ 8.9 Bn by the year 2032. According to a recent study by Future Market Insights, peripheral vascular stents are leading the market with a share of about 78.5% in the year 2021, within the global market.

Market Outlook:

Data Points

Market Insights

Market Value 2021

US$ 4.5 Bn

Market Value 2022

US$ 4.7 Bn

Market Value 2032

US$ 8.9 Bn

CAGR 2022-2032

6.6%

Market Share of Top 5 Countries

57.6%

Key Market Players

Abbott Laboratories, Boston Scientific Corporation, Cook Medical Inc., MicroPort Scientific Corporation (Endovastec™), Medtronic Plc., Cardinal Health, Inc., B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Becton, Dickinson and Company, W. L. Gore & Associates Inc., Getinge AB, Terumo Corp, Kyoto Medical Planning Co Ltd, iVascular S.L.U, AMG International GmbH, ENDOCOR GmbH, Meril Life Sciences Pvt. Ltd., Nano Therapeutics Pvt Ltd, Koninklijke Philips N.V., and REVA Medical

Plaque in the arteries that carry blood to the body is the primary cause of the peripheral arterial disease (PAD). It generally suggests systemic atherosclerosis and an elevated risk of cardiovascular events. Diabetic patients, smokers, the elderly, and those with cardiovascular disease are most vulnerable to PAD. About half of persons with PAD are asymptomatic, regardless of whether it causes symptoms, PAD can imply systemic atherosclerosis and an elevated risk of heart disease and stroke. Many novel technologies, as well as new versions of existing devices, are now available for endovascular, less invasive treatment of PAD.

Customize this Report

Let us know your requirement to get
100% FREE customization

Sales Analysis of Peripheral Vascular Devices Market from 2012 to 2021 Vs Market Outlook for 2022 to 2032

The market value for peripheral vascular devices was approximately 52.0% of the overall ~US$ 8.6 Bn of the global stents market in 2021.

The sales of peripheral vascular devices expanded at a CAGR of 4.4% from 2012 to 2021, owing to a high incidence of cardiovascular disease burden, globally.

Minimally invasive endovascular procedures to expand the artery opening, such as angioplasty or atherectomy, are currently employed more frequently than bypass surgery as the initial treatment strategy for PAD. The two primary forms of endovascular therapies for PAD are balloon angioplasty with stenting and atherectomy. Endovascular therapy or vascular surgery can be used to treat patients with severe PAD.

A large volume of the population worldwide suffers from critical limb ischemia (CLI), the most severe form of peripheral arterial disease (PAD). While endovascular therapy has been the first choice of treatment in the majority of cases, there is still a range of barriers to the best treatment of diseases such as infrapopliteal (IP) disease.

Endovascular therapy outcomes have significantly improved as technology has advanced. Several innovative technologies are now being developed, including intravascular lithotripsy, percutaneous femoro-popliteal bypass, paclitaxel-eluting stents, and the adventitial delivery of anti-restenosis medicines.

As the world's population has grown, so has the demand for healthcare services. Due to an increase in the senior population, the number of individuals suffering from cardiovascular disorders has continually increased. As a result, the demand for devices used in the treatment of cardiovascular disorders has increased. Peripheral vascular devices can be used to treat a variety of heart and arterial problems.

Additionally, technological developments have had a favourable impact on the market shares for peripheral vascular devices. Moreover, the rapid growth of the healthcare industry in developing nations has a beneficial impact on the peripheral vascular devices market growth.

Thus, owing to the aforementioned factors, the global peripheral vascular devices market is expected to grow at a CAGR of 6.6% during the forecast period from 2022 to 2032.

Peripheral Vascular Devices Market Download Report Brochure

What are the Key Opportunities for the Peripheral Vascular Devices Market Manufacturers?

The market for peripheral vascular devices is set to be presented with opportunistic growth over the forecast period. This growth is expected to be owed to the introduction of novel products, such as upgraded drug-eluting vascular stents.

The FDA granted Boston Scientific an investigational device exemption (IDE) in 2015 to initiate a global, pivotal study of the Eluvia drug-eluting stent. EluviaTM Drug-Eluting Vascular Stent System was designed exclusively for the treatment of peripheral artery disease, and in 2018, the U.S. Food and Drug Administration (FDA) authorised its Premarket Approval (PMA) application.

Stents were first created as a tube that could be inserted intraluminally out of a metal alloy. Bare metal stents (BMSs), coated stents, and drug-eluting stents (DESs) are all types of stents that have evolved in recent years. They may also be self-expanding and balloon expandable. Stents are currently mostly made of nickel and titanium, stainless steel, cobalt chromium, or nickel and titanium.

Biodegradable polymers have been used to create bioabsorbable stents. Although the concept of a bioabsorbable material holds promise, it has not been established in randomised controlled studies and has not demonstrated enhanced or equivalent patency when compared to endarterectomy and PTA.

With the research and development required to improve the outcomes over more standardised approaches, the key players are presented with lucrative prospects for advancement.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Factors Restraining Demand for Peripheral Vascular Devices?

The growth of the peripheral vascular devices market is restricted by factors that include device recall activities, device limitations, and the high cost of advanced devices. Medtronic issued the FDA’s most serious type of medical device recall, Class I, in response to reports of injuries associated with its HawkOne system for clearing blocked arteries. About 95,000 devices sold to the United States since 2018 were subject to the recall, which Medtronic announced in early December 2021.

Moreover, the material cost composition of peripheral vascular devices is greater within institutional settings, and the high-cost burden of adoption of these devices is a factor, which hinders the overall market.

Additionally, device limitations during the surgical procedure further pose a restrictive impact upon the market expansion. Several procedures utilizing drug-eluting balloons come with the risk of occurrence of restenosis after treatment.

Keeping the above factors into consideration, the global market for peripheral vascular stents is subject to repression, in terms of growth, over the forecast period.

Country-wise Insights

What Makes the U.S. a Large Market for Peripheral Vascular Devices?

The U.S. dominates the North American region with a total market share of about 94.5% in 2021 and is expected to continue to experience the same growth throughout the forecast period. With a large population suffering from cardiovascular disorders, the product adoption rate for peripheral vascular devices is quite high within the country, thus propelling the U.S. into being the largest contributor towards the growth of the global peripheral vascular stents market.

What Makes China a Highly Lucrative Market for Peripheral Vascular Devices?

China holds approximately 56.5% share in the East Asia market in 2021 and is projected to display growth at a lucrative CAGR of 8.5% during the forecast period. China presents lucrative prospects for the growth of the overall market, owing to a prospective, multi-center, randomized, and controlled, superiority trial was done at 14 hospitals in China as part of the FREEWAY-CHINA project.

The objective of this study was to assess the effectiveness and safety of the FREEWAY paclitaxel-coated balloon. According to the study, the FREEWAY paclitaxel-coated balloon outperformed the uncoated balloon in Chinese patients' target lesion revascularization at the 6- and 12-month mark. With established device adaptability and efficacy in the demographic, the market is poised to be fuelled by future product adoption within the country.

What is the Outlook of Germany in the Peripheral Vascular Devices Market?

Germany is set to exhibit a CAGR of nearly 6.0% in the European peripheral vascular devices market during the forecast period. The market expansion in Germany is owed to the large geriatric population, advanced medical device technology and research, and a high prevalence of chronic diseases.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Category-wise Insights

Which Peripheral Vascular Devices Product is Driving Market Growth?

Peripheral vascular stents are expected to present high growth at a CAGR of 6.0% by the end of the forecast period. With angioplasty procedures, the use of peripheral vascular stents is adapted for implantation into the artery for the removal of calcified lesions. A large disease population globally calls for a greater number of procedures involving the adoption of peripheral vascular stents, thus promoting this segment’s overall market value.

What Indication within the Peripheral Vascular Devices is Largely in Focus Globally?

Peripheral arterial disease holds a revenue share of 30.3% in the global market in 2021. Growing urban lifestyle, as well as a large population consuming alcohol and tobacco, are factors propelling the development of peripheral arterial disease. This segment thus holds a major focus within the market.

What Type of Artery is Largely in Focus within the Peripheral Vascular Devices Market Globally?

lliac artery holds a global revenue share of around 48.1% in 2021. Claudication and/or critical limb ischemia are primarily caused by aortoiliac disease, which has a prevalence of up to 10% in the general population and up to 20% in people over the age of 70 (Annals of Vascular Surgery, 2017). Peripheral artery disease includes aortoiliac occlusive disease.

A substantial portion of the global market for peripheral vascular devices is focused on the iliac artery segment due to increased concerns about this condition.

Which End User Benefits the Most From the Sales of Peripheral Vascular Devices Globally?

Hospitals hold the highest market share of about 60.4% during the year 2021. The growing prevalence of chronic and infectious diseases, as well as the associated increasing volumes of surgical procedures, have driven this segment to be a dominant fragment, propelling sales of the overall peripheral vascular devices market.

Competitive Landscape

The overall market is highly fragmented, with multiple rivals in the peripheral vascular device production sphere. These companies are using techniques such as mergers and acquisitions, partnerships and collaborations, and new product releases to meet consumer demand and expand their customer base.

  • Cook Medical obtained FDA Breakthrough Device designation for a novel drug-eluting stent for below the knee in January 2022. (BTK). This novel stent is intended to treat individuals with chronic limb-threatening ischemia (CLTI).
  • Cordis, a Cardinal Health business, acquired new group purchasing product agreements with Premier on June 10, 2019, for eight interventional product categories. The Vascular Closure Devices (VCD) agreement went into effect on June 1st, while the coronary accords went into effect on July 1st.

Similarly, recent developments related to companies manufacturing peripheral vascular devices, have been tracked by the team at Future Market Insights, which are available in the full report.

Report Scope as per Peripheral Vascular Devices Industry Analysis

Attribute

Details

Forecast Period

2012-2021

Historical Data Available for

2022-2032

Market Analysis

US$ Mn for Value

Key Regions Covered

North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa

Key Countries Covered

U.S., Canada, Brazil, Mexico, Argentina, U.K., Germany, Italy, Russia, Spain, France, BENELUX, Nordic countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, Israel, North Africa, and South Africa

Key Market Segments Covered

Product, Indication, Artery, End User, and Region

Key Companies Profiled

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • MicroPort Scientific Corporation (Endovastec™)
  • Medtronic Plc.
  • Cardinal Health, Inc.
  • B. Braun Melsungen AG
  • BIOTRONIK SE & Co. KG
  • Becton, Dickinson and Company
  • W. L. Gore & Associates Inc.
  • Getinge AB
  • Terumo Corp
  • Kyoto Medical Planning Co Ltd
  • iVascular S.L.U
  • AMG International GmbH
  • ENDOCOR GmbH
  • Meril Life Sciences Pvt. Ltd.
  • Nano Therapeutics Pvt Ltd
  • Koninklijke Philips N.V.
  • REVA Medical

Pricing

Available upon Request

Key Market Segments Covered in Peripheral Vascular Devices Industry Research

By Product:

  • Peripheral Vascular Stents
    • Self-Expanding Stents
    • Balloon Expanding Stents
    • Covered Stents
  • Drug Eluting Stents
  • Drug Eluting Balloons
  • Peripheral Vascular Bioresorbable Scaffolds

By Indication:

  • Target Artery Instability (TAI)
  • Access Artery Injury (AAI)
  • Peripheral Arterial Disease
  • Arteriovenous Fistulas
  • Peripheral Aneurysms
  • Others

By Artery:

  • Carotid Artery
  • Fem-Pop Artery
  • lliac Artery
  • Infrapop Artery

By End User:

  • Hospitals
  • Ambulatory Surgical Centers/Outpatients
  • Cardiac Catheterization Labs

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global peripheral vascular devices market is worth US$ 4.5 Bn in 2021 and is set to expand 1.9X over the next ten years.

The peripheral vascular devices market is expected to reach US$ 8.9 Bn by the end of 2032, with sales revenue expected to register 6.6% CAGR.

The growing burden of cardiovascular diseases, rising awareness regarding cardiovascular procedures, and the adoption of minimally invasive surgical techniques are some of the key trends in this market.

The U.S., China, Germany, U.K., and India are expected to drive demand for the peripheral vascular devices industry.

Demand for peripheral vascular devices in South Asia is expected to register a 7.1% CAGR over the next ten years.

North America is one of the key markets for peripheral vascular devices, with the U.S. accounting for about 94.5% of the North American peripheral vascular devices market in the year 2021.

Demand for peripheral vascular devices in Europe is expected to register a 6.2% CAGR over the next ten years.

The U.S., China, and Germany are the key producers of peripheral vascular devices.

Demand for peripheral vascular devices in MEA is expected to register a 5.7% CAGR over the next ten years.

Abbott Laboratories, Boston Scientific Corporation, Cook Medical Inc., MicroPort Scientific Corporation (Endovastec™), Medtronic Plc., Cardinal Health, Inc., B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Becton, Dickinson and Company, W. L. Gore & Associates Inc., Getinge AB, Terumo Corp, Kyoto Medical Planning Co Ltd, iVascular S.L.U, AMG International GmbH, ENDOCOR GmbH, Meril Life Sciences Pvt. Ltd., Nano Therapeutics Pvt Ltd, Koninklijke Philips N.V., and REVA Medical, are some of the key pl

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply-Side Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Product Adoption / Usage Analysis

    4.2. Product USP Analysis

    4.3. Key Strategies adopted by manufacturers

    4.4. Regulatory Scenario

    4.5. Technology Assessment

    4.6. Value Chain Analysis

    4.7. Recent Product Launches

    4.8. PESTLE Analysis

    4.9. Porter’s Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Spending Outlook

        5.1.3. Global Stent Market Overview

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Rising Number of Peripheral Surgeries

        5.2.2. Technological Advancements

        5.2.3. Regulatory Landscape

        5.2.4. Cost of Procedures

        5.2.5. Product Adoption Rate and Demand

        5.2.6. Increase in Research and Development

        5.2.7. Pharmaceutical Industry Consolidation Activities

        5.2.8. Top Companies’ Historical Growth

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

    6.1. COVID-19 and Impact Analysis

        6.1.1. By Product

        6.1.2. By Indication

        6.1.3. By Artery

        6.1.4. By End User

        6.1.5. By Region

    6.2. 2021 Market Scenario

7. Global Market Volume (Thousands) Analysis 2012–2021 and Forecast, 2022–2032

    7.1. Historical Market Volume (Thousands) Analysis, 2012–2021

    7.2. Current and Future Market Volume (Thousands) Projections, 2022–2032

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

    8.1. Regional Pricing Analysis By Product

    8.2. Pricing Break Up

        8.2.1. Manufacturer Level

        8.2.2. Distributor Level

    8.3. Global Average Pricing Analysis Benchmark

    8.4. Pricing Assumptions

9. Global Market Demand (in Value or Size in US$ Mn) Analysis 2012-2021 and Forecast, 2022–2032

    9.1. Historical Market Value (US$ Mn) Analysis 2012-2021

    9.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2012-2021 and Forecast 2022–2032, By Product

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Volume (Thousands) Analysis By Product, 2012-2021

    10.3. Current and Future Market Size (US$ Mn) and Volume (Thousands) Analysis and Forecast By Product, 2022–2032

        10.3.1. Peripheral Vascular Stents

            10.3.1.1. Self-Expanding Stents

            10.3.1.2. Balloon Expanding Stents

            10.3.1.3. Covered Stents

            10.3.1.4. Drug Eluting Stents

        10.3.2. Drug Eluting Balloons

        10.3.3. Peripheral Vascular Bioresorbable Scaffolds

    10.4. Market Attractiveness Analysis By Product

11. Global Market Analysis 2012-2021 and Forecast 2022–2032, By Indication

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Indication, 2012-2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2022–2032

        11.3.1. Target Artery Instability (TAI)

        11.3.2. Access Artery Injury (AAI)

        11.3.3. Peripheral Arterial Disease

        11.3.4. Arteriovenous Fistulas

        11.3.5. Peripheral Aneurysms

        11.3.6. Others

    11.4. Market Attractiveness Analysis By Indication

12. Global Market Analysis 2012-2021 and Forecast 2022–2032, By Artery

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By Artery, 2012-2021

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Artery, 2022–2032

        12.3.1. Carotid Artery

        12.3.2. Fem-Pop Artery

        12.3.3. Iliac Artery

        12.3.4. Infrapop Artery

    12.4. Market Attractiveness Analysis By Artery

13. Global Market Analysis 2012-2021 and Forecast 2022–2032, By End User

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By End User, 2012-2021

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032

        13.3.1. Hospitals

        13.3.2. Ambulatory Surgical Centers/Outpatients

        13.3.3. Cardiac Catheterization Labs

    13.4. Market Attractiveness Analysis By End User

14. Global Market Analysis 2012-2021 and Forecast 2022–2032, by Region

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) and Volume (Thousands) Analysis By Region, 2012-2021

    14.3. Current and Future Market Size (US$ Mn) and Volume (Thousands) Analysis and Forecast By Region, 2022–2032

        14.3.1. North America

        14.3.2. Latin America

        14.3.3. Europe

        14.3.4. South Asia

        14.3.5. East Asia

        14.3.6. Oceania

        14.3.7. Middle East & Africa (MEA)

    14.4. Market Attractiveness Analysis By Region

15. North America Market Analysis 2012-2021 and Forecast 2022–2032

    15.1. Introduction / Key Findings

    15.2. Historical Market Size (US$ Mn) and Volume (Thousands) Analysis By Region, 2012-2021

    15.3. Current and Future Market Size (US$ Mn) and Volume (Thousands) Analysis and Forecast By Region, 2022–2032

        15.3.1. By Country

            15.3.1.1. U.S.

            15.3.1.2. Canada

        15.3.2. By Product

        15.3.3. By Indication

        15.3.4. By Artery

        15.3.5. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Product

        15.4.2. By Indication

        15.4.3. By Artery

        15.4.4. By End User

        15.4.5. By Country

    15.5. Market Trends

    15.6. Key Market Participants - Intensity Mapping

    15.7. Drivers and Restraints - Impact Analysis

    15.8. Country Level Analysis & Forecast

        15.8.1. U.S. Market

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast by Market Taxonomy

                15.8.1.2.1. By Product

                15.8.1.2.2. By Indication

                15.8.1.2.3. By Artery

                15.8.1.2.4. By End User

        15.8.2. Canada Market

        15.8.3. Introduction

        15.8.4. Market Analysis and Forecast by Market Taxonomy

                15.8.4.1.1. By Product

                15.8.4.1.2. By Indication

                15.8.4.1.3. By Artery

                15.8.4.1.4. By End User

16. Latin America Market Analysis 2012-2021 and Forecast 2022–2032

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) and Volume (Thousands) Analysis By Market Taxonomy, 2012-2021

    16.3. Current and Future Market Size (US$ Mn) and Volume (Thousands) Analysis and Forecast By Market Taxonomy, 2022–2032

        16.3.1. By Country

            16.3.1.1. Brazil

            16.3.1.2. Mexico

            16.3.1.3. Argentina

            16.3.1.4. Rest of Latin America

        16.3.2. By Product

        16.3.3. By Indication

        16.3.4. By Artery

        16.3.5. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Product

        16.4.2. By Indication

        16.4.3. By Artery

        16.4.4. By End User

        16.4.5. By Country

    16.5. Market Trends

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

    16.8. Country Level Analysis & Forecast

        16.8.1. Brazil Market

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast by Market Taxonomy

                16.8.1.2.1. By Product

                16.8.1.2.2. By Indication

                16.8.1.2.3. By Artery

                16.8.1.2.4. By End User

        16.8.2. Mexico Market

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast by Market Taxonomy

                16.8.2.2.1. By Product

                16.8.2.2.2. By Indication

                16.8.2.2.3. By Artery

                16.8.2.2.4. By End User

        16.8.3. Argentina Market

        16.8.4. Introduction

        16.8.5. Market Analysis and Forecast by Market Taxonomy

                16.8.5.1. By Product

                16.8.5.2. By Indication

                16.8.5.3. By Artery

                16.8.5.4. By End User

17. Europe Market Analysis 2012-2021 and Forecast 2022–2032

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) and Volume (Thousands) Analysis By Market Taxonomy, 2012-2021

    17.3. Current and Future Market Size (US$ Mn) and Volume (Thousands) Analysis and Forecast By Market Taxonomy, 2022–2032

        17.3.1. By Country

            17.3.1.1. Germany

            17.3.1.2. Italy

            17.3.1.3. France

            17.3.1.4. U.K.

            17.3.1.5. Spain

            17.3.1.6. BENELUX

            17.3.1.7. Russia

            17.3.1.8. Nordic Countries

            17.3.1.9. Rest of Europe

        17.3.2. By Product

        17.3.3. By Indication

        17.3.4. By Artery

        17.3.5. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Product

        17.4.2. By Indication

        17.4.3. By Artery

        17.4.4. By End User

        17.4.5. By Country

    17.5. Market Trends

    17.6. Key Market Participants - Intensity Mapping

    17.7. Drivers and Restraints - Impact Analysis

    17.8. Country Level Analysis & Forecast

        17.8.1. Germany Market

            17.8.1.1. Introduction

            17.8.1.2. Market Analysis and Forecast by Market Taxonomy

                17.8.1.2.1. By Product

                17.8.1.2.2. By Indication

                17.8.1.2.3. By Artery

                17.8.1.2.4. By End User

        17.8.2. Italy Market

            17.8.2.1. Introduction

            17.8.2.2. Market Analysis and Forecast by Market Taxonomy

                17.8.2.2.1. By Product

                17.8.2.2.2. By Indication

                17.8.2.2.3. By Artery

                17.8.2.2.4. By End User

        17.8.3. France Market

            17.8.3.1. Introduction

            17.8.3.2. Market Analysis and Forecast by Market Taxonomy

                17.8.3.2.1. By Product

                17.8.3.2.2. By Indication

                17.8.3.2.3. By Artery

                17.8.3.2.4. By End User

        17.8.4. U.K. Market

            17.8.4.1. Introduction

            17.8.4.2. Market Analysis and Forecast by Market Taxonomy

                17.8.4.2.1. By Product

                17.8.4.2.2. By Indication

                17.8.4.2.3. By Artery

                17.8.4.2.4. By End User

        17.8.5. Spain Market

            17.8.5.1. Introduction

            17.8.5.2. Market Analysis and Forecast by Market Taxonomy

                17.8.5.2.1. By Product

                17.8.5.2.2. By Indication

                17.8.5.2.3. By Artery

                17.8.5.2.4. By End User

        17.8.6. BENELUX Market

            17.8.6.1. Introduction

            17.8.6.2. Market Analysis and Forecast by Market Taxonomy

                17.8.6.2.1. By Product

                17.8.6.2.2. By Indication

                17.8.6.2.3. By Artery

                17.8.6.2.4. By End User

        17.8.7. Russia Market

            17.8.7.1. Introduction

            17.8.7.2. Market Analysis and Forecast by Market Taxonomy

                17.8.7.2.1. By Product

                17.8.7.2.2. By Indication

                17.8.7.2.3. By Artery

                17.8.7.2.4. By End User

        17.8.8. Nordic Countries Market

            17.8.8.1. Introduction

            17.8.8.2. Market Analysis and Forecast by Market Taxonomy

                17.8.8.2.1. By Product

                17.8.8.2.2. By Indication

                17.8.8.2.3. By Artery

                17.8.8.2.4. By End User

18. East Asia Market Analysis 2012-2021 and Forecast 2022–2032

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) and Volume (Thousands) Analysis By Market Taxonomy, 2012-2021

    18.3. Current and Future Market Size (US$ Mn) and Volume (Thousands) Analysis and Forecast By Market Taxonomy, 2022–2032

        18.3.1. By Country

            18.3.1.1. China

            18.3.1.2. Japan

            18.3.1.3. South Korea

        18.3.2. By Product

        18.3.3. By Indication

        18.3.4. By Artery

        18.3.5. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Product

        18.4.2. By Indication

        18.4.3. By Artery

        18.4.4. By End User

        18.4.5. By Country

    18.5. Market Trends

    18.6. Key Market Participants - Intensity Mapping

    18.7. Drivers and Restraints - Impact Analysis

    18.8. Country Level Analysis & Forecast

        18.8.1. China Market

            18.8.1.1. Introduction

            18.8.1.2. Market Analysis and Forecast by Market Taxonomy

                18.8.1.2.1. By Product

                18.8.1.2.2. By Indication

                18.8.1.2.3. By Artery

                18.8.1.2.4. By End User

        18.8.2. Japan Market

            18.8.2.1. Introduction

            18.8.2.2. Market Analysis and Forecast by Market Taxonomy

                18.8.2.2.1. By Product

                18.8.2.2.2. By Indication

                18.8.2.2.3. By Artery

                18.8.2.2.4. By End User

        18.8.3. South Korea Market

            18.8.3.1. Introduction

            18.8.3.2. Market Analysis and Forecast by Market Taxonomy

                18.8.3.2.1. By Product

                18.8.3.2.2. By Indication

                18.8.3.2.3. By Artery

                18.8.3.2.4. By End User

19. South Asia Market Analysis 2012-2021 and Forecast 2022–2032

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) and Volume (Thousands) Analysis By Market Taxonomy, 2012-2021

    19.3. Current and Future Market Size (US$ Mn) and Volume (Thousands) Analysis and Forecast By Market Taxonomy, 2022–2032

        19.3.1. By Country

            19.3.1.1. India

            19.3.1.2. Indonesia

            19.3.1.3. Malaysia

            19.3.1.4. Thailand

            19.3.1.5. Rest of South Asia

        19.3.2. By Product

        19.3.3. By Indication

        19.3.4. By Artery

        19.3.5. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Product

        19.4.2. By Indication

        19.4.3. By Artery

        19.4.4. By End User

        19.4.5. By Country

    19.5. Market Trends

    19.6. Key Market Participants - Intensity Mapping

    19.7. Drivers and Restraints - Impact Analysis

    19.8. Country Level Analysis & Forecast

        19.8.1. India Market

            19.8.1.1. Introduction

            19.8.1.2. Market Analysis and Forecast by Market Taxonomy

                19.8.1.2.1. By Product

                19.8.1.2.2. By Indication

                19.8.1.2.3. By Artery

                19.8.1.2.4. By End User

        19.8.2. Indonesia Market

            19.8.2.1. Introduction

            19.8.2.2. Market Analysis and Forecast by Market Taxonomy

                19.8.2.2.1. By Product

                19.8.2.2.2. By Indication

                19.8.2.2.3. By Artery

                19.8.2.2.4. By End User

        19.8.3. Malaysia Market

            19.8.3.1. Introduction

            19.8.3.2. Market Analysis and Forecast by Market Taxonomy

                19.8.3.2.1. By Product

                19.8.3.2.2. By Indication

                19.8.3.2.3. By Artery

                19.8.3.2.4. By End User

        19.8.4. Thailand Market

            19.8.4.1. Introduction

            19.8.4.2. Market Analysis and Forecast by Market Taxonomy

                19.8.4.2.1. By Product

                19.8.4.2.2. By Indication

                19.8.4.2.3. By Artery

                19.8.4.2.4. By End User

20. Oceania Market Analysis 2012-2021 and Forecast 2022–2032

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) and Volume (Thousands) Analysis By Market Taxonomy, 2012-2021

    20.3. Current and Future Market Size (US$ Mn) and Volume (Thousands) Analysis and Forecast By Market Taxonomy, 2022–2032

        20.3.1. By Country

            20.3.1.1. Australia

            20.3.1.2. New Zealand

        20.3.2. By Product

        20.3.3. By Indication

        20.3.4. By Artery

        20.3.5. By End User

    20.4. Market Attractiveness Analysis

        20.4.1. By Product

        20.4.2. By Indication

        20.4.3. By Artery

        20.4.4. By End User

        20.4.5. By Country

    20.5. Market Trends

    20.6. Key Market Participants - Intensity Mapping

    20.7. Drivers and Restraints - Impact Analysis

    20.8. Country Level Analysis & Forecast

        20.8.1. Australia Market

            20.8.1.1. Introduction

            20.8.1.2. Market Analysis and Forecast by Market Taxonomy

                20.8.1.2.1. By Product

                20.8.1.2.2. By Indication

                20.8.1.2.3. By Artery

                20.8.1.2.4. By End User

        20.8.2. New Zealand Market

            20.8.2.1. Introduction

            20.8.2.2. Market Analysis and Forecast by Market Taxonomy

                20.8.2.2.1. By Product

                20.8.2.2.2. By Indication

                20.8.2.2.3. By Artery

                20.8.2.2.4. By End User

21. Middle East and Africa Market Analysis 2012-2021 and Forecast 2022–2032

    21.1. Introduction

    21.2. Historical Market Size (US$ Mn) and Volume (Thousands) Analysis By Market Taxonomy, 2012-2021

    21.3. Current and Future Market Size (US$ Mn) and Volume (Thousands) Analysis and Forecast By Market Taxonomy, 2022–2032

        21.3.1. By Country

            21.3.1.1. GCC Countries

            21.3.1.2. Turkey

            21.3.1.3. Israel

            21.3.1.4. North Africa

            21.3.1.5. South Africa

            21.3.1.6. Rest of Middle East and Africa

        21.3.2. By Product

        21.3.3. By Indication

        21.3.4. By Artery

        21.3.5. By End User

    21.4. Market Attractiveness Analysis

        21.4.1. By Product

        21.4.2. By Indication

        21.4.3. By Artery

        21.4.4. By End User

        21.4.5. By Country

    21.5. Market Trends

    21.6. Key Market Participants - Intensity Mapping

    21.7. Drivers and Restraints - Impact Analysis

    21.8. Country Level Analysis & Forecast

        21.8.1. GCC Countries Market

            21.8.1.1. Introduction

            21.8.1.2. Market Analysis and Forecast by Market Taxonomy

                21.8.1.2.1. By Product

                21.8.1.2.2. By Indication

                21.8.1.2.3. By Artery

                21.8.1.2.4. By End User

        21.8.2. Turkey Market

            21.8.2.1. Introduction

            21.8.2.2. Market Analysis and Forecast by Market Taxonomy

                21.8.2.2.1. By Product

                21.8.2.2.2. By Indication

                21.8.2.2.3. By Artery

                21.8.2.2.4. By End User

        21.8.3. Israel Market

            21.8.3.1. Introduction

            21.8.3.2. Market Analysis and Forecast by Market Taxonomy

                21.8.3.2.1. By Product

                21.8.3.2.2. By Indication

                21.8.3.2.3. By Artery

                21.8.3.2.4. By End User

        21.8.4. North Africa Market

            21.8.4.1. Introduction

            21.8.4.2. Market Analysis and Forecast by Market Taxonomy

                21.8.4.2.1. By Product

                21.8.4.2.2. By Indication

                21.8.4.2.3. By Artery

                21.8.4.2.4. By End User

        21.8.5. South Africa Market

            21.8.5.1. Introduction

            21.8.5.2. Market Analysis and Forecast by Market Taxonomy

                21.8.5.2.1. By Product

                21.8.5.2.2. By Indication

                21.8.5.2.3. By Artery

                21.8.5.2.4. By End User

22. Market Structure Analysis

    22.1. Market Analysis by Tier of Companies

    22.2. Market Share Analysis (%) of Top Players

    22.3. Market Presence Analysis

        22.3.1. Regional Footprint by Players

        22.3.2. Product Footprint by Players

        22.3.3. Channel Foot Print by Players

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Competition Benchmarking

    23.3. Competition Deep Dive

        23.3.1. Abbott Laboratories

            23.3.1.1. Overview

            23.3.1.2. Product Portfolio

            23.3.1.3. Sales Footprint

            23.3.1.4. Key Financials

            23.3.1.5. SWOT Analysis

            23.3.1.6. Strategy Overview

                23.3.1.6.1. Marketing Strategy

                23.3.1.6.2. Product strategy

                23.3.1.6.3. Channel Strategy

        23.3.2. Boston Scientific Corporation

            23.3.2.1. Overview

            23.3.2.2. Product Portfolio

            23.3.2.3. Sales Footprint

            23.3.2.4. Key Financials

            23.3.2.5. SWOT Analysis

            23.3.2.6. Strategy Overview

                23.3.2.6.1. Marketing Strategy

                23.3.2.6.2. Product strategy

                23.3.2.6.3. Channel Strategy

        23.3.3. Cook Medical Inc.

            23.3.3.1. Overview

            23.3.3.2. Product Portfolio

            23.3.3.3. Sales Footprint

            23.3.3.4. Key Financials

            23.3.3.5. SWOT Analysis

            23.3.3.6. Strategy Overview

                23.3.3.6.1. Marketing Strategy

                23.3.3.6.2. Product strategy

                23.3.3.6.3. Channel Strategy

        23.3.4. MicroPort Scientific Corporation (Endovastec™)

            23.3.4.1. Overview

            23.3.4.2. Product Portfolio

            23.3.4.3. Sales Footprint

            23.3.4.4. Key Financials

            23.3.4.5. SWOT Analysis

            23.3.4.6. Strategy Overview

                23.3.4.6.1. Marketing Strategy

                23.3.4.6.2. Product strategy

                23.3.4.6.3. Channel Strategy

        23.3.5. Medtronic Plc.

            23.3.5.1. Overview

            23.3.5.2. Product Portfolio

            23.3.5.3. Sales Footprint

            23.3.5.4. Key Financials

            23.3.5.5. SWOT Analysis

            23.3.5.6. Strategy Overview

                23.3.5.6.1. Marketing Strategy

                23.3.5.6.2. Product strategy

                23.3.5.6.3. Channel Strategy

        23.3.6. Cardinal Health, Inc.

            23.3.6.1. Overview

            23.3.6.2. Product Portfolio

            23.3.6.3. Sales Footprint

            23.3.6.4. Key Financials

            23.3.6.5. SWOT Analysis

            23.3.6.6. Strategy Overview

                23.3.6.6.1. Marketing Strategy

                23.3.6.6.2. Product strategy

                23.3.6.6.3. Channel Strategy

        23.3.7. B. Braun Melsungen AG

            23.3.7.1. Overview

            23.3.7.2. Product Portfolio

            23.3.7.3. Sales Footprint

            23.3.7.4. Key Financials

            23.3.7.5. SWOT Analysis

            23.3.7.6. Strategy Overview

                23.3.7.6.1. Marketing Strategy

                23.3.7.6.2. Product strategy

                23.3.7.6.3. Channel Strategy

        23.3.8. BIOTRONIK SE & Co. KG

            23.3.8.1. Overview

            23.3.8.2. Product Portfolio

            23.3.8.3. Sales Footprint

            23.3.8.4. Key Financials

            23.3.8.5. SWOT Analysis

            23.3.8.6. Strategy Overview

                23.3.8.6.1. Marketing Strategy

                23.3.8.6.2. Product strategy

                23.3.8.6.3. Channel Strategy

        23.3.9. Becton, Dickinson and Company

            23.3.9.1. Overview

            23.3.9.2. Product Portfolio

            23.3.9.3. Sales Footprint

            23.3.9.4. Key Financials

            23.3.9.5. SWOT Analysis

            23.3.9.6. Strategy Overview

                23.3.9.6.1. Marketing Strategy

                23.3.9.6.2. Product strategy

                23.3.9.6.3. Channel Strategy

        23.3.10. W. L. Gore & Associates Inc.

            23.3.10.1. Overview

            23.3.10.2. Product Portfolio

            23.3.10.3. Sales Footprint

            23.3.10.4. Key Financials

            23.3.10.5. SWOT Analysis

            23.3.10.6. Strategy Overview

                23.3.10.6.1. Marketing Strategy

                23.3.10.6.2. Product strategy

                23.3.10.6.3. Channel Strategy

        23.3.11. Getinge AB

            23.3.11.1. Overview

            23.3.11.2. Product Portfolio

            23.3.11.3. Sales Footprint

            23.3.11.4. Key Financials

            23.3.11.5. SWOT Analysis

            23.3.11.6. Strategy Overview

                23.3.11.6.1. Marketing Strategy

                23.3.11.6.2. Product strategy

                23.3.11.6.3. Channel Strategy

        23.3.12. Terumo Corp

            23.3.12.1. Overview

            23.3.12.2. Product Portfolio

            23.3.12.3. Sales Footprint

            23.3.12.4. Key Financials

            23.3.12.5. SWOT Analysis

            23.3.12.6. Strategy Overview

                23.3.12.6.1. Marketing Strategy

                23.3.12.6.2. Product strategy

                23.3.12.6.3. Channel Strategy

        23.3.13. Kyoto Medical Planning Co Ltd

            23.3.13.1. Overview

            23.3.13.2. Product Portfolio

            23.3.13.3. Sales Footprint

            23.3.13.4. Key Financials

            23.3.13.5. SWOT Analysis

            23.3.13.6. Strategy Overview

                23.3.13.6.1. Marketing Strategy

                23.3.13.6.2. Product strategy

                23.3.13.6.3. Channel Strategy

        23.3.14. iVascular S.L.U

            23.3.14.1. Overview

            23.3.14.2. Product Portfolio

            23.3.14.3. Sales Footprint

            23.3.14.4. Key Financials

            23.3.14.5. SWOT Analysis

            23.3.14.6. Strategy Overview

                23.3.14.6.1. Marketing Strategy

                23.3.14.6.2. Product strategy

                23.3.14.6.3. Channel Strategy

        23.3.15. AMG International GmbH

            23.3.15.1. Overview

            23.3.15.2. Product Portfolio

            23.3.15.3. Sales Footprint

            23.3.15.4. Key Financials

            23.3.15.5. SWOT Analysis

            23.3.15.6. Strategy Overview

                23.3.15.6.1. Marketing Strategy

                23.3.15.6.2. Product strategy

                23.3.15.6.3. Channel Strategy

        23.3.16. ENDOCOR GmbH

            23.3.16.1. Overview

            23.3.16.2. Product Portfolio

            23.3.16.3. Sales Footprint

            23.3.16.4. Key Financials

            23.3.16.5. SWOT Analysis

            23.3.16.6. Strategy Overview

                23.3.16.6.1. Marketing Strategy

                23.3.16.6.2. Product strategy

                23.3.16.6.3. Channel Strategy

        23.3.17. Meril Life Sciences Pvt. Ltd.

            23.3.17.1. Overview

            23.3.17.2. Product Portfolio

            23.3.17.3. Sales Footprint

            23.3.17.4. Key Financials

            23.3.17.5. SWOT Analysis

            23.3.17.6. Strategy Overview

                23.3.17.6.1. Marketing Strategy

                23.3.17.6.2. Product strategy

                23.3.17.6.3. Channel Strategy

        23.3.18. Nano Therapeutics Pvt Ltd

            23.3.18.1. Overview

            23.3.18.2. Product Portfolio

            23.3.18.3. Sales Footprint

            23.3.18.4. Key Financials

            23.3.18.5. SWOT Analysis

            23.3.18.6. Strategy Overview

                23.3.18.6.1. Marketing Strategy

                23.3.18.6.2. Product strategy

                23.3.18.6.3. Channel Strategy

        23.3.19. Koninklijke Philips N.V.

            23.3.19.1. Overview

            23.3.19.2. Product Portfolio

            23.3.19.3. Sales Footprint

            23.3.19.4. Key Financials

            23.3.19.5. SWOT Analysis

            23.3.19.6. Strategy Overview

                23.3.19.6.1. Marketing Strategy

                23.3.19.6.2. Product strategy

                23.3.19.6.3. Channel Strategy

        23.3.20. REVA Medical

            23.3.20.1. Overview

            23.3.20.2. Product Portfolio

            23.3.20.3. Sales Footprint

            23.3.20.4. Key Financials

            23.3.20.5. SWOT Analysis

            23.3.20.6. Strategy Overview

                23.3.20.6.1. Marketing Strategy

                23.3.20.6.2. Product strategy

                23.3.20.6.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Market Size (US$ Mn) Analysis 2012–2021, By Product

Table 02: Global Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Product

Table 03: Global Market Volume (in Thousands)  Analysis 2012–2021 and Forecast, 2022–2032, By Product

Table 04: Global Market Volume (in Thousands)  Analysis 2012–2021 and Forecast, 2022–2032, By Product

Table 05: Global Market Size (US$ Mn) Analysis 2012–2021, By Indication

Table 06: Global Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Indication

Table 07: Global Market Size (US$ Mn) Analysis 2012–2021, By Artery

Table 08: Global Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Artery

Table 09: Global Market Size (US$ Mn) Analysis 2012–2021, By End User

Table 10: Global Market Size (US$ Mn) Opportunity Assessment 2022–2032, By End User

Table 11: Global Market Size (US$ Mn) Analysis 2012–2021, By Region

Table 12: Global Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Region

Table 13: Global Market Volume (in Thousands)  Analysis 2012–2021 and Forecast, 2022–2032, By Region

Table 14: Global Market Volume (in Thousands)  Analysis 2012–2021 and Forecast, 2022–2032, By Region

Table 15: North America Market Size (US$ Mn) Analysis 2012–2021, By Product

Table 16: North America Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Product

Table 17: North America Market Volume (in Thousands)  Analysis 2012–2021 and Forecast, 2022–2032, By Product

Table 18: North America Market Volume (in Thousands)  Analysis 2012–2021 and Forecast, 2022–2032, By Product

Table 19: North America Market Size (US$ Mn) Analysis 2012–2021, By Indication

Table 20: North America Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Indication

Table 21: North America Market Size (US$ Mn) Analysis 2012–2021, By Artery

Table 22: North America Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Artery

Table 23: North America Market Size (US$ Mn) Analysis 2012–2021, By End User

Table 24: North America Market Size (US$ Mn) Opportunity Assessment 2022–2032, By End User

Table 25: North America Market Size (US$ Mn) Analysis 2012–2021, By Country

Table 26: North America Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Country

Table 27: Latin America Market Size (US$ Mn) Analysis 2012–2021, By Product

Table 28: Latin America Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Product

Table 29: Latin America Market Volume (in Thousands)  Analysis 2012–2021 and Forecast, 2022–2032, By Product

Table 30: Latin America Market Volume (in Thousands)  Analysis 2012–2021 and Forecast, 2022–2032, By Product

Table 31: Latin America Market Size (US$ Mn) Analysis 2012–2021, By Indication

Table 32: Latin America Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Indication

Table 33: Latin America Market Size (US$ Mn) Analysis 2012–2021, By Artery

Table 34: Latin America Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Artery

Table 35: Latin America Market Size (US$ Mn) Analysis 2012–2021, By End User

Table 36: Latin America Market Size (US$ Mn) Opportunity Assessment 2022–2032, By End User

Table 37: Latin America Market Size (US$ Mn) Analysis 2012–2021, By Country

Table 38: Latin America Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Country

Table 39: Europe Market Size (US$ Mn) Analysis 2012–2021, By Product

Table 40: Europe Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Product

Table 41: Europe Market Volume (in Thousands)  Analysis 2012–2021 and Forecast, 2022–2032, By Product

Table 42: Europe Market Volume (in Thousands)  Analysis 2012–2021 and Forecast, 2022–2032, By Product

Table 43: Europe Market Size (US$ Mn) Analysis 2012–2021, By Indication

Table 44: Europe Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Indication

Table 45: Europe Market Size (US$ Mn) Analysis 2012–2021, By Artery

Table 46: Europe Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Artery

Table 47: Europe Market Size (US$ Mn) Analysis 2012–2021, By End User

Table 48: Europe Market Size (US$ Mn) Opportunity Assessment 2022–2032, By End User

Table 49: Europe Market Size (US$ Mn) Analysis 2012–2021, By Country

Table 50: Europe Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Country

Table 51: East Asia Market Size (US$ Mn) Analysis 2012–2021, By Product

Table 52: East Asia Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Product

Table 53: East Asia Market Volume (in Thousands)  Analysis 2012–2021 and Forecast, 2022–2032, By Product

Table 54: East Asia Market Volume (in Thousands)  Analysis 2012–2021 and Forecast, 2022–2032, By Product

Table 55: East Asia Market Size (US$ Mn) Analysis 2012–2021, By Indication

Table 56: East Asia Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Indication

Table 57: East Asia Market Size (US$ Mn) Analysis 2012–2021, By Artery

Table 58: East Asia Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Artery

Table 59: East Asia Market Size (US$ Mn) Analysis 2012–2021, By End User

Table 60: East Asia Market Size (US$ Mn) Opportunity Assessment 2022–2032, By End User

Table 61: East Asia Market Size (US$ Mn) Analysis 2012–2021, By Country

Table 62: East Asia Market Size (US$ Mn) Opportunity Assessment 2022–2032, By End User

Table 63: South Asia Market Size (US$ Mn) Analysis 2012–2021, By Product

Table 64: South Asia Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Product

Table 65: South Asia Market Volume (in Thousands)  Analysis 2012–2021 and Forecast, 2022–2032, By Product

Table 66: South Asia Market Volume (in Thousands)  Analysis 2012–2021 and Forecast, 2022–2032, By Product

Table 67: South Asia Market Size (US$ Mn) Analysis 2012–2021, By Indication

Table 68: South Asia Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Indication

Table 69: South Asia Market Size (US$ Mn) Analysis 2012–2021, By Artery

Table 70: South Asia Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Artery

Table 71: South Asia Market Size (US$ Mn) Analysis 2012–2021, By End User

Table 72: South Asia Market Size (US$ Mn) Opportunity Assessment 2022–2032, By End User

Table 73: South Asia Market Size (US$ Mn) Analysis 2012–2021, By Country

Table 74: South Asia Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Country

Table 75: Oceania Market Size (US$ Mn) Analysis 2012–2021, By Product

Table 76: Oceania Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Product

Table 77: Oceania Market Volume (in Thousands)  Analysis 2012–2021 and Forecast, 2022–2032, By Product

Table 78: Oceania Market Volume (in Thousands)  Analysis 2012–2021 and Forecast, 2022–2032, By Product

Table 79: Oceania Market Size (US$ Mn) Analysis 2012–2021, By Indication

Table 80: Oceania Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Indication

Table 81: Oceania Market Size (US$ Mn) Analysis 2012–2021, By Artery

Table 82: Oceania Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Artery

Table 83: Oceania Market Size (US$ Mn) Analysis 2012–2021, By End User

Table 84: Oceania Market Size (US$ Mn) Opportunity Assessment 2022–2032, By End User

Table 85: Oceania Market Size (US$ Mn) Analysis 2012–2021, By Country

Table 86: Oceania Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Country

Table 87: MEA Market Size (US$ Mn) Analysis 2012–2021, By Product

Table 88: MEA Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Product

Table 89: MEA Market Volume (in Thousands)  Analysis 2012–2021 and Forecast, 2022–2032, By Product

Table 90: MEA Market Volume (in Thousands)  Analysis 2012–2021 and Forecast, 2022–2032, By Product

Table 91: MEA Market Size (US$ Mn) Analysis 2012–2021, By Indication

Table 92: MEA Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Indication

Table 93: MEA Market Size (US$ Mn) Analysis 2012–2021, By Artery

Table 94: MEA Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Artery

Table 95: MEA Market Size (US$ Mn) Analysis 2012–2021, By End User

Table 96: MEA Market Size (US$ Mn) Opportunity Assessment 2022–2032, By End User

Table 97: MEA Market Size (US$ Mn) Analysis 2012–2021, By Country

Table 98: MEA Market Size (US$ Mn) Opportunity Assessment 2022–2032, By Country

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Market Volume (in Thousands) Analysis, 2012–2021 

Figure 02: Global Market Volume (in Thousands) & Y-o-Y Growth (%) Forecast, 2022–2032 

Figure 03: Global Average Pricing Analysis Benchmark US$ per unit (2021)

Figure 04: Global Market Value Analysis (US$ Mn), 2012–2021

Figure 05: Global Market Value Forecast (US$ Mn), 2022–2032

Figure 06: Global Market Absolute $ Opportunity, 2021–2032

Figure 07: Global Market Share Analysis (%), By Product, 2022 & 2032

Figure 08: Global Market Y-o-Y Analysis (%), By Product, 2022–2032

Figure 09: Global Market Attractiveness Analysis By Product, 2022–2032

Figure 10: Global Market Share Analysis (%), By Indication, 2022 & 2032

Figure 11: Global Market Y-o-Y Analysis (%), By Indication, 2022–2032

Figure 12: Global Market Attractiveness Analysis By Indication, 2022–2032

Figure 13: Global Market Share Analysis (%), By Artery, 2022 & 2032

Figure 14: Global Market Y-o-Y Analysis (%), By Artery, 2022–2032

Figure 15: Global Market Attractiveness Analysis By Artery, 2022–2032

Figure 16: Global Market Share Analysis (%), By End User, 2022 & 2032

Figure 17: Global Market Y-o-Y Analysis (%), By End User, 2022–2032

Figure 18: Global Market Attractiveness Analysis By End User, 2022–2032

Figure 19: Global Market Share Analysis (%), By Region, 2022 & 2032

Figure 20: Global Market Y-o-Y Analysis (%), By Region, 2022–2032

Figure 21: Global Market Attractiveness Analysis By Region, 2022–2032

Figure 22: North America Market Value Share By Product 2022 (E)

Figure 23: North America Market Value Share By End User 2022 (E)

Figure 24: North America Market Value Share By Artery 2022 (E)

Figure 25: North America Market Value Share By End User 2022 (E)

Figure 26: North America Market Value Share By Country 2022 (E)

Figure 27: North America Market Attractiveness Analysis By Product, 2022–2032

Figure 28: North America Market Attractiveness Analysis By Indication, 2022–2032

Figure 29: North America Market Attractiveness Analysis by Artery, 2022-2032

Figure 30: North America Market Attractiveness Analysis by End User, 2022-2032

Figure 31: North America Market Attractiveness Analysis by Country, 2022-2032

Figure 32: U.S. Market Value Proportion Analysis, 2021

Figure 33: U.S. Market Share Analysis (%), By Product, 2021 & 2032

Figure 34: U.S. Market Share Analysis (%), By Indication, 2021 & 2032

Figure 35: U.S. Market Share Analysis (%), By Artery, 2021 & 2032

Figure 36: U.S. Market Share Analysis (%), By End User, 2021 & 2032

Figure 37 : Canada Market Value Proportion Analysis, 2021

Figure 38: Canada Market Share Analysis (%), By Product, 2021 & 2032

Figure 39: Canada Market Share Analysis (%), By Indication, 2021 & 2032

Figure 40: Canada Market Share Analysis (%), By Artery, 2021 & 2032

Figure 41: Canada Market Share Analysis (%), By End User, 2021 & 2032

Figure 42: Latin America Market Value Share By Product 2022 (E)

Figure 43: Latin America Market Value Share By End User 2022 (E)

Figure 44: Latin America Market Value Share By Artery 2022 (E)

Figure 45: Latin America Market Value Share By End User 2022 (E)

Figure 46: Latin America Market Value Share By Country 2022 (E)

Figure 47: Latin America Market Attractiveness Analysis By Product, 2022–2032

Figure 48: Latin America Market Attractiveness Analysis By Indication, 2022–2032

Figure 49: Latin America Market Attractiveness Analysis by Artery, 2022-2032

Figure 50: Latin America Market Attractiveness Analysis by End User, 2022-2032

Figure 51: Latin America Market Attractiveness Analysis by Country, 2022-2032

Figure 52 : Brazil Market Value Proportion Analysis, 2021

Figure 53: Brazil Market Share Analysis (%), By Product, 2021 & 2032

Figure 54: Brazil Market Share Analysis (%), By Indication, 2021 & 2032

Figure 55: Brazil Market Share Analysis (%), By Artery, 2021 & 2032

Figure 56: Brazil Market Share Analysis (%), By End User, 2021 & 2032

Figure 57 : Mexico Market Value Proportion Analysis, 2021

Figure 58: Mexico Market Share Analysis (%), By Product, 2021 & 2032

Figure 59: Mexico Market Share Analysis (%), By Indication, 2021 & 2032

Figure 60: Mexico Market Share Analysis (%), By Artery, 2021 & 2032

Figure 61: Mexico Market Share Analysis (%), By End User, 2021 & 2032

Figure 62 : Argentina Market Value Proportion Analysis, 2021

Figure 63: Argentina Market Share Analysis (%), By Product, 2021 & 2032

Figure 64: Argentina Market Share Analysis (%), By Indication, 2021 & 2032

Figure 65: Argentina Market Share Analysis (%), By Artery, 2021 & 2032

Figure 66: Argentina Market Share Analysis (%), By End User, 2021 & 2032

Figure 67: Europe Market Value Share By Product 2022 (E)

Figure 68: Europe Market Value Share By End User 2022 (E)

Figure 69: Europe Market Value Share By Artery 2022 (E)

Figure 70: Europe Market Value Share By End User 2022 (E)

Figure 71: Europe Market Value Share By Country 2022 (E)

Figure 72: Europe Market Attractiveness Analysis By Product, 2022–2032

Figure 73: Europe Market Attractiveness Analysis By Indication, 2022–2032

Figure 74: Europe Market Attractiveness Analysis by Artery, 2022-2032

Figure 75: Europe Market Attractiveness Analysis by End User, 2022-2032

Figure 76: Europe Market Attractiveness Analysis by Country, 2022-2032

Figure 77 : Germany Market Value Proportion Analysis, 2021

Figure 78: Germany Market Share Analysis (%), By Product, 2021 & 2032

Figure 79: Germany Market Share Analysis (%), By Indication, 2021 & 2032

Figure 80: Germany Market Share Analysis (%), By Artery, 2021 & 2032

Figure 81: Germany Market Share Analysis (%), By End User, 2021 & 2032

Figure 82 : Italy Market Value Proportion Analysis, 2021

Figure 83: Italy Market Share Analysis (%), By Product, 2021 & 2032

Figure 84: Italy Market Share Analysis (%), By Indication, 2021 & 2032

Figure 85: Italy Market Share Analysis (%), By Artery, 2021 & 2032

Figure 86: Italy Market Share Analysis (%), By End User, 2021 & 2032

Figure 87 : France Market Value Proportion Analysis, 2021

Figure 88: France Market Share Analysis (%), By Product, 2021 & 2032

Figure 89: France Market Share Analysis (%), By Indication, 2021 & 2032

Figure 90: France Market Share Analysis (%), By Artery, 2021 & 2032

Figure 91: France Market Share Analysis (%), By End User, 2021 & 2032

Figure 92 : U.K. Market Value Proportion Analysis, 2021

Figure 93: U.K. Market Share Analysis (%), By Product, 2021 & 2032

Figure 94: U.K. Market Share Analysis (%), By Indication, 2021 & 2032

Figure 95: U.K. Market Share Analysis (%), By Artery, 2021 & 2032

Figure 96: U.K. Market Share Analysis (%), By End User, 2021 & 2032

Figure 97 : Spain Market Value Proportion Analysis, 2021

Figure 98: Spain Market Share Analysis (%), By Product, 2021 & 2032

Figure 99: Spain Market Share Analysis (%), By Indication, 2021 & 2032

Figure 100: Spain Market Share Analysis (%), By Artery, 2021 & 2032

Figure 101: Spain Market Share Analysis (%), By End User, 2021 & 2032

Figure 102 : BENELLUX Market Value Proportion Analysis, 2021

Figure 103: BENELLUX Market Share Analysis (%), By Product, 2021 & 2032

Figure 104: BENELLUX Market Share Analysis (%), By Indication, 2021 & 2032

Figure 105: BENELLUX Market Share Analysis (%), By Artery, 2021 & 2032

Figure 106: BENELLUX Market Share Analysis (%), By End User, 2021 & 2032

Figure 107 : Russia Market Value Proportion Analysis, 2021

Figure 108: Russia Market Share Analysis (%), By Product, 2021 & 2032

Figure 109: Russia Market Share Analysis (%), By Indication, 2021 & 2032

Figure 110: Russia Market Share Analysis (%), By Artery, 2021 & 2032

Figure 111: Russia Market Share Analysis (%), By End User, 2021 & 2032

Figure 112 : Nordic Countries Market Value Proportion Analysis, 2021

Figure 113: Nordic Countries Market Share Analysis (%), By Product, 2021 & 2032

Figure 114: Nordic Countries Market Share Analysis (%), By Indication, 2021 & 2032

Figure 115: Nordic Countries Market Share Analysis (%), By Artery, 2021 & 2032

Figure 116: Nordic Countries Market Share Analysis (%), By End User, 2021 & 2032

Figure 117: East Asia Market Value Share By Product 2022 (E)

Figure 118: East Asia Market Value Share By End User 2022 (E)

Figure 119: East Asia Market Value Share By Artery 2022 (E)

Figure 120: East Asia Market Value Share By End User 2022 (E)

Figure 121: East Asia Market Value Share By Country 2022 (E)

Figure 122: East Asia Market Attractiveness Analysis By Product, 2022–2032

Figure 123: East Asia Market Attractiveness Analysis By Indication, 2022–2032

Figure 124: East Asia Market Attractiveness Analysis by Artery, 2022-2032

Figure 125: East Asia Market Attractiveness Analysis by End User, 2022-2032

Figure 126: East Asia Market Attractiveness Analysis by Country, 2022-2032

Figure 127 : China Market Value Proportion Analysis, 2021

Figure 128: China Market Share Analysis (%), By Product, 2021 & 2032

Figure 129: China Market Share Analysis (%), By Indication, 2021 & 2032

Figure 130: China Market Share Analysis (%), By Artery, 2021 & 2032

Figure 131: China. Market Share Analysis (%), By End User, 2021 & 2032

Figure 132 : Japan Market Value Proportion Analysis, 2021

Figure 133: Japan Market Share Analysis (%), By Product, 2021 & 2032

Figure 134: Japan Market Share Analysis (%), By Indication, 2021 & 2032

Figure 135: Japan Market Share Analysis (%), By Artery, 2021 & 2032

Figure 136: Japan Market Share Analysis (%), By End User, 2021 & 2032

Figure 137 : South Korea Market Value Proportion Analysis, 2021

Figure 138: South Korea Market Share Analysis (%), By Product, 2021 & 2032

Figure 139: South Korea Market Share Analysis (%), By Indication, 2021 & 2032

Figure 140: South Korea Market Share Analysis (%), By Artery, 2021 & 2032

Figure 141: South Korea. Market Share Analysis (%), By End User, 2021 & 2032

Figure 142: South Asia Market Value Share By Product 2022 (E)

Figure 143: South Asia Market Value Share By End User 2022 (E)

Figure 144: South Asia Market Value Share By Artery 2022 (E)

Figure 145: South Asia Market Value Share By End User 2022 (E)

Figure 146: South Asia Market Value Share By Country 2022 (E)

Figure 147: South Asia Market Attractiveness Analysis By Product, 2022–2032

Figure 148: South Asia Market Attractiveness Analysis By Indication, 2022–2032

Figure 149: South Asia Market Attractiveness Analysis by Artery, 2022-2032

Figure 150: South Asia Market Attractiveness Analysis by End User, 2022-2032

Figure 151: South Asia Market Attractiveness Analysis by Country, 2022-2032

Figure 152 : India Market Value Proportion Analysis, 2021

Figure 153: India Market Share Analysis (%), By Product, 2021 & 2032

Figure 154: India Market Share Analysis (%), By Indication, 2021 & 2032

Figure 155: India Market Share Analysis (%), By Artery, 2021 & 2032

Figure 156: India Market Share Analysis (%), By End User, 2021 & 2032

Figure 157 : Indonesia Market Value Proportion Analysis, 2021

Figure 158: Indonesia Market Share Analysis (%), By Product, 2021 & 2032

Figure 159: Indonesia Market Share Analysis (%), By Indication, 2021 & 2032

Figure 160: Indonesia Market Share Analysis (%), By Artery, 2021 & 2032

Figure 161: Indonesia Market Share Analysis (%), By End User, 2021 & 2032

Figure 162 : Malaysia Market Value Proportion Analysis, 2021

Figure 163: Malaysia Market Share Analysis (%), By Product, 2021 & 2032

Figure 164: Malaysia Market Share Analysis (%), By Indication, 2021 & 2032

Figure 165: Malaysia Market Share Analysis (%), By Artery, 2021 & 2032

Figure 166: Malaysia Market Share Analysis (%), By End User, 2021 & 2032

Figure 167 : Thailand Market Value Proportion Analysis, 2021

Figure 168: Thailand Market Share Analysis (%), By Product, 2021 & 2032

Figure 169: Thailand Market Share Analysis (%), By Indication, 2021 & 2032

Figure 170: Thailand Market Share Analysis (%), By Artery, 2021 & 2032

Figure 171: Thailand Market Share Analysis (%), By End User, 2021 & 2032

Figure 172: Oceania Market Value Share By Product 2022 (E)

Figure 173: Oceania Market Value Share By End User 2022 (E)

Figure 174: Oceania Market Value Share By Artery 2022 (E)

Figure 175: Oceania Market Value Share By End User 2022 (E)

Figure 176: Oceania Market Value Share By Country 2022 (E)

Figure 177: Oceania Market Attractiveness Analysis By Product, 2022–2032

Figure 178: Oceania Market Attractiveness Analysis By Indication, 2022–2032

Figure 179: Oceania Market Attractiveness Analysis by Artery, 2022-2032

Figure 180: Oceania Market Attractiveness Analysis by End User, 2022-2032

Figure 181: Oceania Market Attractiveness Analysis by Country, 2022-2032

Figure 182 : Australia Market Value Proportion Analysis, 2021

Figure 183: Australia Market Share Analysis (%), By Product, 2021 & 2032

Figure 184: Australia Market Share Analysis (%), By Indication, 2021 & 2032

Figure 185: Australia Market Share Analysis (%), By Artery, 2021 & 2032

Figure 186: Australia Market Share Analysis (%), By End User, 2021 & 2032

Figure 187 : New Zealand Market Value Proportion Analysis, 2021

Figure 188: New Zealand Market Share Analysis (%), By Product, 2021 & 2032

Figure 189: New Zealand Market Share Analysis (%), By Indication, 2021 & 2032

Figure 190: New Zealand Market Share Analysis (%), By Artery, 2021 & 2032

Figure 191: New Zealand Market Share Analysis (%), By End User, 2021 & 2032

Figure 192: MEA Market Value Share By Product 2022 (E)

Figure 193: MEA Market Value Share By End User 2022 (E)

Figure 194: MEA Market Value Share By Artery 2022 (E)

Figure 195: MEA Market Value Share By End User 2022 (E)

Figure 196: MEA Market Value Share By Country 2022 (E)

Figure 197: MEA Market Attractiveness Analysis By Product, 2022–2032

Figure 198: MEA Market Attractiveness Analysis By Indication, 2022–2032

Figure 199: MEA Market Attractiveness Analysis by Artery, 2022-2032

Figure 200: MEA Market Attractiveness Analysis by End User, 2022-2032

Figure 201: MEA Market Attractiveness Analysis by Country, 2022-2032

Figure 202 : GCC Countries Market Value Proportion Analysis, 2021

Figure 203: GCC Countries Market Share Analysis (%), By Product, 2021 & 2032

Figure 204: GCC Countries  Peripheral Vascular Devices Market Share Analysis (%), By Indication, 2021 & 2032

Figure 205: GCC Countries  Peripheral Vascular Devices Market Share Analysis (%), By Artery, 2021 & 2032

Figure 206: GCC Countries Market Share Analysis (%), By End User, 2021 & 2032

Figure 207 : Turkey Market Value Proportion Analysis, 2021

Figure 208: Turkey Market Share Analysis (%), By Product, 2021 & 2032

Figure 209: Turkey Market Share Analysis (%), By Indication, 2021 & 2032

Figure 210: Turkey Market Share Analysis (%), By Artery, 2021 & 2032

Figure 211: Turkey Market Share Analysis (%), By End User, 2021 & 2032

Figure 212 : Israel Market Value Proportion Analysis, 2021

Figure 213: Israel Market Share Analysis (%), By Product, 2021 & 2032

Figure 214: Israel Market Share Analysis (%), By Indication, 2021 & 2032

Figure 215: Israel Market Share Analysis (%), By Artery, 2021 & 2032

Figure 216: Israel Market Share Analysis (%), By End User, 2021 & 2032

Figure 217 : North Africa Market Value Proportion Analysis, 2021

Figure 218: North Africa Market Share Analysis (%), By Product, 2021 & 2032

Figure 219: North Africa Market Share Analysis (%), By Indication, 2021 & 2032

Figure 220: North Africa Market Share Analysis (%), By Artery, 2021 & 2032

Figure 221: North Africa Market Share Analysis (%), By End User, 2021 & 2032

Figure 222 : South Africa Market Value Proportion Analysis, 2021

Figure 223: South Africa Market Share Analysis (%), By Product, 2021 & 2032

Figure 224: South Africa Market Share Analysis (%), By Indication, 2021 & 2032

Figure 225: South Africa Market Share Analysis (%), By Artery, 2021 & 2032

Figure 226: South Africa Market Share Analysis (%), By End User, 2021 & 2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Heart Block Therapeutics Market

Published : June 2022

Healthcare

Dual Balloon Angioplasty Catheter Market

Published : September 2017

Healthcare

Aortic Stents Grafts Market

Published : December 2021

Google translate

Peripheral Vascular Devices Market